000 01118 a2200325 4500
005 20250517200146.0
264 0 _c20190517
008 201905s 0 0 eng d
022 _a1557-7422
024 7 _a10.1089/hum.2017.243
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSiegler, Elizabeth Louise
245 0 0 _aPreclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.
_h[electronic resource]
260 _bHuman gene therapy
_c05 2018
300 _a534-546 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xtrends
650 0 4 _aImmunotherapy, Adoptive
_xtrends
650 0 4 _aMice
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aReceptors, Chimeric Antigen
_ximmunology
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTumor Microenvironment
_ximmunology
700 1 _aWang, Pin
773 0 _tHuman gene therapy
_gvol. 29
_gno. 5
_gp. 534-546
856 4 0 _uhttps://doi.org/10.1089/hum.2017.243
_zAvailable from publisher's website
999 _c28034529
_d28034529